Tuesday, April 16, 2013

Stocks DD Cites: Taro Pharma - SA article


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article


http://seekingalpha.com/article/1339201-my-thoughts-on-taro

If you like to receive free updates on stocks directly to your email inbox, click on the subscribe via mail icon situated on the top right of this blog.

Saturday, April 6, 2013

Stocks DD Cites: Trius's Tedozolid differentiation from Pfizer's Linezolid


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article

Presentation->Link

See slide 20, where they say 40% of Linezolid's sales (in off-label indication where long term dosing is needed)  and Linezolid safety is questionable. Tedozolid does well in safety signals in long term dosing . I think the major concern was generic linezolid in 2016 but this above data would likely put that concern to rest?





If you like to receive free updates on stocks directly to your email inbox, click on the subscribe via mail icon situated on the top right of this blog.